Literature DB >> 29709974

Respiratory Syncytial Virus Surveillance System in Japan: Assessment of Recent Trends, 2008-2015.

Kazuhiko Kanou1, Yuzo Arima1, Hitomi Kinoshita1, Hiroaki Ito2, Hideo Okuno1, Naruo Saito3, Tomimasa Sunagawa1, Hirokazu Kimura1, Tamano Matsui1, Kazunori Oishi1.   

Abstract

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract illness in infants and young children. In Japan, surveillance for RSV infection started in 2003 based on approximately 3,000 pediatric sentinel sites. In recent years, RSV notifications have increased, but the interpretation of trends has been challenging due to a suspected increase in testing frequency and the expansion of the insurance coverage for RSV testing to include certain outpatients in late 2011. Therefore, we evaluated RSV surveillance data during 2008-2015, considering the number of sites that reported at least one RSV case during a surveillance year and restricting to sites that had continuous reporting status since 2008. While annual RSV notifications had increased, the number of sites reporting also increased. And the same magnitude of increase was not observed when the number of cases reported was restricted to the 1,372 sites that had continuous reporting status since 2008. Additionally, in the year following the insurance expansion, RSV notifications increased more remarkably for clinics than for hospitals. These results suggested that some of the recent increases in notifications might be due to an increase in testing frequency.

Entities:  

Keywords:  Japan; assessment; pediatric; respiratory syncytial virus; sentinel surveillance

Mesh:

Year:  2018        PMID: 29709974     DOI: 10.7883/yoken.JJID.2017.261

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  4 in total

1.  A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese adults.

Authors:  Yuji Orito; Naoyuki Otani; Yuki Matsumoto; Katsukuni Fujimoto; Nobuyuki Oshima; Brian M Maas; Luzelena Caro; Antonios O Aliprantis; Kara S Cox; Osamu Tokumaru; Masaaki Kodama; Hideo Kudo; Hiromitsu Imai; Naoto Uemura
Journal:  Clin Transl Sci       Date:  2022-05-17       Impact factor: 4.438

2.  Quantifying the causal impact of funding bedside antigen testing on the incidence of respiratory syncytial virus infection in Japan: a difference-in-differences study.

Authors:  Sung-Mok Jung; Hyojung Lee; Yichi Yang; Hiroshi Nishiura
Journal:  Ann Transl Med       Date:  2020-11

3.  Comparison of infections with respiratory syncytial virus between children and adults: a multicenter surveillance from 2015 to 2019 in Beijing, China.

Authors:  Ming Luo; Cheng Gong; Yan Zhang; Xue Wang; Yang Liu; Qing Luo; Maozhong Li; Aihua Li; Yiting Wang; Mei Dong; Wenbo Xu; Fang Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-10-05       Impact factor: 5.103

4.  Respiratory syncytial virus in the Western Pacific Region: a systematic review and meta-analysis.

Authors:  Krisna N A Pangesti; Moataz Abd El Ghany; Alison M Kesson; Grant A Hill-Cawthorne
Journal:  J Glob Health       Date:  2019-12       Impact factor: 4.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.